--- title: "Electromed (ELMD) stock listing, news and investor profile" url: "https://aibio.space/companies/electromed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Electromed, Inc. (NYSE: ELMD), United States. Listing facts, related biotech companies and news on aibio.space." --- ELMD Electromed, Inc. NYSE · United States # Electromed (ELMD) news Electromed, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker ELMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Electromed news We have not published a story on Electromed yet. When there is news, it will appear here. ## Electromed at a glance - **Ticker**: ELMD - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $20.4 million ### Related companies - [Burning Rock Biotech](https://aibio.space/companies/burning-rock-biotech/) NASDAQ: BNR - [Freenome](https://aibio.space/companies/freenome/) NASDAQ: FRNM - [METTLER TOLEDO INTERNATIONAL INC/](https://aibio.space/companies/mettler-toledo-international/) NYSE: MTD - [Opthea](https://aibio.space/companies/opthea/) OTC: CKDXF - [Vireo Growth](https://aibio.space/companies/vireo-growth/) OTC: VREOF - [RadNet](https://aibio.space/companies/radnet/) NASDAQ: RDNT - [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) NASDAQ: VIVS - [Stereotaxis](https://aibio.space/companies/stereotaxis/) NYSE: STXS ### Also on NYSE - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) EW - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) INFU - [Johnson & Johnson](https://aibio.space/companies/johnson-johnson/) JNJ - [Glass House Brands](https://aibio.space/companies/glass-house-brands/) GLAS - [Stereotaxis](https://aibio.space/companies/stereotaxis/) STXS - [Hercules Capital](https://aibio.space/companies/hercules-capital/) HTGC ## What Electromed does Electromed, Inc. develops, manufactures, markets and sells airway clearance therapy, led by the SmartVest Airway Clearance System, which delivers high frequency chest wall oscillation (HFCWO) to patients with compromised pulmonary function. The company primarily uses a direct-to-patient and provider model. It obtains referrals from clinicians, manages insurance claims for patients, delivers the system to their homes and trains them on its use. It also sells into the acute care setting for patients after surgery, in intensive care, or admitted for a lung infection. Since 2000 it has marketed SmartVest and its predecessor products to patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The FDA has cleared the SmartVest System to promote airway clearance and improve bronchial drainage, and the system is available only with a physician prescription. The company was incorporated in Minnesota in 1992 and is listed on the NYSE American under the ticker ELMD. | Product or program | What it is | Stage | |---|---|---| | SmartVest Clearway | Next generation HFCWO airway clearance system with inflatable garment and programmable generator | FDA cleared; available only with a physician prescription | | SmartVest SQL | HFCWO airway clearance model sold into homecare and hospital markets | Currently available | Summarised from the company's [10-K filed Aug 25, 2026](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/elmd20260630_10k.htm). ## Electromed annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Research and development | [$1.3 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | [$996,000](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | | Net income (loss) | [$11.3 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | [$7.5 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | | Cash from operations | [$9.7 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | [$11.4 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | | Cash and equivalents | [$20.4 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | [$15.3 million](https://www.sec.gov/Archives/edgar/data/1488917/000143774926028914/) | Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $20.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Electromed What is the ticker symbol of Electromed? Electromed, Inc. trades under the ticker ELMD on NYSE. Where is Electromed listed? Electromed, Inc. is listed on NYSE. Which country or territory is Electromed listed under? Our directory records Electromed, Inc. under United States. Does aibio.space cover Electromed? aibio.space lists Electromed, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What does Electromed develop? Electromed, Inc. develops, manufactures, markets and sells airway clearance therapy, led by the SmartVest Airway Clearance System, which delivers high frequency chest wall oscillation (HFCWO) to patients with compromised pulmonary function. The company primarily uses a direct-to-patient and provider model. What is SmartVest Clearway from Electromed? SmartVest Clearway: Next generation HFCWO airway clearance system with inflatable garment and programmable generator Stage: FDA cleared; available only with a physician prescription. What is SmartVest SQL from Electromed? SmartVest SQL: HFCWO airway clearance model sold into homecare and hospital markets Stage: Currently available. Is Electromed profitable? Electromed, Inc. reported net income of $11.3 million for the fiscal year ended Jun 30, 2026, and generated $9.7 million of cash from operations, per its annual report to the SEC. How much does Electromed spend on research and development? $1.3 million in the fiscal year ended Jun 30, 2026, per its annual report. How much cash does Electromed have? $20.4 million in cash at Jun 30, 2026, per its 10-K. ## Investor discussion: Electromed Members talk about Electromed (ELMD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:ELMD on TradingView](https://www.tradingview.com/symbols/NYSE-ELMD/). ## Listing details Electromed, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker ELMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Electromed, Inc. - **Ticker**: ELMD - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/electromed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Electromed (ELMD) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/electromed/